Results 151 to 160 of about 546,162 (334)
Urinary microbes and postoperative urinary tract infection risk in urogynecologic surgical patients
K. Thomas-White+8 more
semanticscholar +1 more source
Treatment of chronic urinary tract infections with gentamicin [PDF]
Anna‐Lena Lindberg+2 more
openalex +1 more source
The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley +1 more source
Experience with Nalidixic Acid in the Treatment of Urinary Tract Infections of Children [PDF]
S. Autio, Petra Mäkelä, R Sunila
openalex +1 more source
Abstract Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in clinical practice, it remains challenging to identify the appropriate timing to start SGLT2 ...
Ruggero Mazzotta+10 more
wiley +1 more source
Eva Raphael,1,2 Lorenzo Argante,3 Elisa Cinconze,3 Sara Nannizzi,3 Cheyenne Belmont,1 Claire F Mastrangelo,4 Yuan Hu Allegretti,5 Michele Pellegrini,3 Johannes E Schmidt3 1Department of Epidemiology and Biostatistics, University of California, San ...
Raphael E+8 more
doaj
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons+17 more
wiley +1 more source
Synthetic Biology‐Based Engineering Living Therapeutics for Antimicrobial Application
This perspective highlights synthetic biology‐driven antibacterial strategies, focusing on three innovative approaches: engineered bacteriophages for precision bacterial targeting, reprogrammed microbes that detect quorum‐sensing signals or metabolites to release antimicrobials, and engineering mammalian cells that recognize pathogen‐associated ...
Shun Huang+4 more
wiley +1 more source
Urinary tract infection in infancy. [PDF]
Paul O’Neill, C. G. H. Newman
openalex +1 more source